Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study

Bud Bilanich
Success Coach

Joe Jackson
Healthcare Engagement Solutions

Tony Schueth, MS
EHR Strategies

Brenda Snow
Authentic Patient Voice

Adrienne Stevens, EdD
HCP Insights

Sarah Caldwell
Data & Analytics

Julia Laurin
Medication Adherence

Don Feiler
Brand Engagement